Log in to save to my catalogue

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_078d157a88ef4291962f3fd4a23d6ee1

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy

About this item

Full title

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical and translational medicine, 2024-04, Vol.14 (4), p.e1656-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Organoid technology is an emerging and rapidly growing field that shows promise in studying organ development and screening therapeutic regimens. Although organoids have been proposed for a decade, concerns exist, including batch‐to‐batch variations, lack of the native microenvironment and clinical applicability.
Main body
The c...

Alternative Titles

Full title

Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_078d157a88ef4291962f3fd4a23d6ee1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_078d157a88ef4291962f3fd4a23d6ee1

Other Identifiers

ISSN

2001-1326

E-ISSN

2001-1326

DOI

10.1002/ctm2.1656

How to access this item